Search Results - "Kern, Michael André"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2
  3. 3

    Targeting heat shock protein 90 with non‐quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma by Breinig, Marco, Caldas‐Lopes, Eloisi, Goeppert, Benjamin, Malz, Mona, Rieker, Ralf, Bergmann, Frank, Schirmacher, Peter, Mayer, Matthias, Chiosis, Gabriela, Kern, Michael André

    Published in Hepatology (Baltimore, Md.) (01-07-2009)
    “…The inhibition of heat shock protein 90 (Hsp90) has emerged as a promising antineoplastic strategy in diverse human malignancies. Hsp90 has been predicted to…”
    Get full text
    Journal Article
  4. 4

    Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis by TÖX, Ulrich, SCHELLER, Ingo, STEFFEN, Hans Michael, KOCIOK, Norbert, KERN, Michael André, KLANAC, Dejan, SHARIF MOHAMMED DAUDI, LAUE, Oliver, SCHIRMACHER, Peter, GOESER, Tobias, SCHULTE, Sigrid

    Published in Digestive diseases and sciences (01-08-2007)
    “…In this study, we assessed the hypothesis that the expression of angiotensin II receptor type 1 (AGTR1) in liver tissue changes with increasing fibrosis, which…”
    Get full text
    Journal Article
  5. 5

    Differential expression of E‐prostanoid receptors in human hepatocellular carcinoma by Breinig, Marco, Rieker, Ralf, Eiteneuer, Eva, Wertenbruch, Tina, Haugg, Anke Maria, Helmke, Burkhard Maria, Schirmacher, Peter, Kern, Michael André

    Published in International journal of cancer (01-02-2008)
    “…Recent studies have shown that inhibition of cyclooxygenases (e.g. COX‐2) exerts antitumorigenic effects on hepatocellular carcinomas (HCCs), which are to a…”
    Get full text
    Journal Article
  6. 6

    DMBT1 expression distinguishes anorectal from cutaneous melanoma by Helmke, Burkhard Maria, Renner, Marcus, Poustka, Annemarie, Schirmacher, Peter, Mollenhauer, Jan, Kern, Michael André

    Published in Histopathology (01-01-2009)
    “…Aims:  Anorectal melanoma (AM) forms a rare but highly malignant subset of mucosal melanoma with an extremely poor prognosis. Although AMs display histological…”
    Get full text
    Journal Article
  7. 7

    Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice by Kern, Michael André, Schöneweiß, Mirja Mareike, Sahi, Dina, Bahlo, Maryam, Haugg, Anke Maria, Kasper, Hans Udo, Dienes, Hans Peter, Käferstein, Herbert, Breuhahn, Kai, Schirmacher, Peter

    Published in Carcinogenesis (New York) (01-07-2004)
    “…Cyclooxygenase (COX)-2 is expressed in hepatocellular carcinomas (HCCs) and HCC cell lines. COX-2 inhibition strongly suppresses growth of HCC cells in vitro…”
    Get full text
    Journal Article
  8. 8

    Her2 overexpression is a rare event in anorectal melanoma by Helmke, Burkhard Maria, Zahel, Tina, Breinig, Marco, Schirmacher, Peter, Aulmann, Sebastian, Kern, Michael André

    Published in Melanoma research (01-10-2010)
    “…Anorectal melanomas (AMs) are very rare and highly malignant tumors that are often diagnosed in advanced stages. After the differentiation between cutaneous…”
    Get full text
    Journal Article
  9. 9

    Cyclooxygenase-2 (COX-2)--a therapeutic target in liver cancer? by Breinig, Marco, Schirmacher, Peter, Kern, Michael André

    Published in Current pharmaceutical design (01-11-2007)
    “…Targeting COX-2, a key-enzyme of the prostaglandin metabolism, for the treatment of cancer has been in the focus of researchers for about a decade. However,…”
    Get more information
    Journal Article
  10. 10

    CONCENTRATIONS OF HEPATOCYTE GROWTH FACTOR IN CEREBROSPINAL FLUID UNDER NORMAL AND DIFFERENT PATHOLOGICAL CONDITIONS by Kern, Michael André, Bamborschke, Stephan, Nekic, Marko, Schubert, Dominic, Rydin, Carolina, Lindholm, Dan, Schirmacher, Peter

    Published in Cytokine (Philadelphia, Pa.) (07-05-2001)
    “…Hepatocyte growth factor (HGF) and its specific receptor, MET, are expressed in the developing and adult mammalian brain. Recent studies have shown a…”
    Get full text
    Journal Article
  11. 11

    Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells by KERN, Michael André, SCHUBERT, Dominic, SAHI, Dina, MAREIKE SCHÖNEWEISS, Mirja, MOLL, Ilona, HAUGG, Anke Maria, DIENES, Hans Peter, BREUHAHN, Kai, SCHIRMACHER, Peter

    Published in Hepatology (Baltimore, Md.) (01-10-2002)
    “…Recent studies have shown increased levels of cyclooxygenase-2 (COX-2) in a variety of human malignancies, including hepatocellular carcinoma (HCC), but so far…”
    Get full text
    Journal Article
  12. 12

    Precision Cut Tissue Slices of the Liver as Morphological Tool for Investigation of Apoptosis by Kasper, Hans-Udo, Dries, Volker, Drebber, Uta, Kern, Michael Andre, Dienes, Hans Peter, Schirmacher, Peter

    Published in In vivo (Athens) (01-03-2005)
    “…Background: Apoptosis, programmed cell death, is involved in a broad range of pathological processes. Dysregulation of apoptosis plays a key role in the…”
    Get full text
    Journal Article
  13. 13

    Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: effects of cyclooxygenase-2 inhibition in hepatocellular carcinoma by Kern, Michael A., Haugg, Anke M., Eiteneuer, Eva, Konze, Elisabeth, Drebber, Uta, Dienes, Hans P., Breuhahn, Kai, Schirmacher, Peter, Kasper, Hans U.

    Published in Liver international (01-06-2006)
    “…: Cultures of precision‐cut tissue slices allow the investigation of substance effects on human tissues under in vivo‐like conditions over a limited time span…”
    Get full text
    Journal Article
  14. 14

    Stage‐extension device for transmission light microscopes by KERN, M. A.

    Published in Journal of microscopy (Oxford) (01-09-2005)
    “…Summary For routine applications, more and more professional microscope users have removed the slide holders from their transmission light microscopes and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells by Kern, Michael André, Schubert, Dominic, Sahi, Dina, Schöneweiß, Mirja Mareike, Moll, Ilona, Haugg, Anke Maria, Dienes, Hans Peter, Breuhahn, Kai, Schirmacher, Peter

    Published in Hepatology (Baltimore, Md.) (2002)
    “…Recent studies have shown increased levels of cyclooxygenase-2 (COX-2) in a variety of human malignancies, including hepatocellular carcinoma (HCC), but so far…”
    Get full text
    Journal Article
  17. 17

    AMYOTROPHIC LATERAL SCLEROSIS: EVIDENCE FOR INTACT HEPATOCYTE GROWTH FACTOR/MET SIGNALLING AXIS by Kern, Michael André, Friese, Michael, Grundstrom, Eva, Korhonen, Laura, Wallin, Anders, Aquilonius, Sten-Magnus, Askmark, Håkan, Schirmacher, Peter, Lindholm, Dan

    Published in Cytokine (Philadelphia, Pa.) (21-09-2001)
    “…Hepatocyte growth factor (HGF) is a secreted cytokine which is expressed in the central nervous system (CNS) together with its specific receptor MET. Since HGF…”
    Get full text
    Journal Article
  18. 18